Article Information
History
- March 23, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Luc-Aimé Kagoué Simeni1,2,*,
- Clauvis Kunkeng Yengo3,†,
- Rodrigue Kamga Wouambo2,4,†,
- Janett Fischer4,††,
- Oumarou M’rikam A Bessong5,
- Joseph Fokam1,6,†† and
- Jules Clément Assob Nguedia5
- 1Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, Cameroon
- 2American Association of Microbiology (ASM), ASM Cameroon, Bangangte, Cameroon
- 3Department of Biochemistry, Faculty of Sciences, University of Yaoundé I
- 4Department of Hepatology, Leipzig University Medical Centre, Leipzig, Germany
- 5SOA health district, ministry of public health, Yaoundé, Cameroon
- 6Virology Laboratory, Chantal BIYA International Reference Centre for Research on HIV/AIDS Prevention and Management, Yaoundé, Cameroon
- 7Faculty of medicine and pharmaceutical sciences, University of Douala, Cameroon
- ↵*Correspondence:
Luc-aimé Kagoué Simeni kagouesimeni{at}gmail.com
↵† These authors contributed equally to this work
Posted March 23, 2023.
KIR2DL1 gene is a surrogate marker of protection against infection-related hospitalisation among HIV-1 unexposed versus exposed uninfected infants in Cameroon
